These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Family in which Duchenne's muscular dystrophy and protan colour blindness are segregating. Greig DN J Med Genet; 1977 Apr; 14(2):130-2. PubMed ID: 300790 [TBL] [Abstract][Full Text] [Related]
67. Severe congenital muscular dystrophy. Zellweger H; Afifi A; McCormick WF; Mergner W Am J Dis Child; 1967 Dec; 114(6):591-602. PubMed ID: 6060021 [No Abstract] [Full Text] [Related]
68. Cardiac arrest following inhalation induction of anaesthesia in a child with Duchenne's muscular dystrophy. Sethna NF; Rockoff MA Can Anaesth Soc J; 1986 Nov; 33(6):799-802. PubMed ID: 3779502 [TBL] [Abstract][Full Text] [Related]
69. Ten years follow up study of steroid therapy for congenital encephalomyopathy. Kinoshita M; Nishina M; Koya N Brain Dev; 1986; 8(3):280-4. PubMed ID: 3766904 [TBL] [Abstract][Full Text] [Related]
70. Transaminitis in Duchenne's muscular dystrophy. Tay SK; Ong HT; Low PS Ann Acad Med Singap; 2000 Nov; 29(6):719-22. PubMed ID: 11269976 [TBL] [Abstract][Full Text] [Related]
71. Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy. Bäckman E; Henriksson KG Neuromuscul Disord; 1995 May; 5(3):233-41. PubMed ID: 7633189 [TBL] [Abstract][Full Text] [Related]
72. Decrease in urinary excretion of 3-methylhistidine by patients with Duchenne muscular dystrophy during glucocorticoid treatment. Kawai H; Adachi K; Nishida Y; Inui T; Kimura C; Saito S J Neurol; 1993; 240(3):181-6. PubMed ID: 8482992 [TBL] [Abstract][Full Text] [Related]
74. Measurement of isometric force in children with and without Duchenne's muscular dystrophy. Brussock CM; Haley SM; Munsat TL; Bernhardt DB Phys Ther; 1992 Feb; 72(2):105-14. PubMed ID: 1549631 [TBL] [Abstract][Full Text] [Related]
75. Purine and carnitine metabolism in muscle of patients with Duchenne muscular dystrophy. Camiña F; Novo-Rodriguez MI; Rodriguez-Segade S; Castro-Gago M Clin Chim Acta; 1995 Dec; 243(2):151-64. PubMed ID: 8747491 [TBL] [Abstract][Full Text] [Related]
76. Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study. Felber S; Skladal D; Wyss M; Kremser C; Koller A; Sperl W Neurol Res; 2000 Mar; 22(2):145-50. PubMed ID: 10763500 [TBL] [Abstract][Full Text] [Related]
77. [Muscle LDH isoenzymes in neuromuscular diseases and in carriers of Duchenne's progressive muscular dystrophy]. Kowalewski S; Rotthauwe HW Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):323. PubMed ID: 4751454 [No Abstract] [Full Text] [Related]
78. Prednisone therapy for Duchenne's muscular dystrophy. Brown RH N Engl J Med; 1989 Jun; 320(24):1621-3. PubMed ID: 2725603 [No Abstract] [Full Text] [Related]
79. Absence of differences in platelet dihydroxyphenylalanine (dopa) oxidase polymorphism in health and Duchenne's muscular dystrophy. Pacold I; Morgan J; Cohen L Clin Genet; 1975; 7(5):435-41. PubMed ID: 807447 [TBL] [Abstract][Full Text] [Related]
80. Prednisone therapy for Duchenne's muscular dystrophy. Oexle K N Engl J Med; 1989 Nov; 321(21):1481-2. PubMed ID: 2811967 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]